USFDA issues 6 observations for Zydus Lifesciences Ahmedabad facility
Advertisement
Ahmedabad: Zydus Lifesciences has announced that the U.S. Food and Drug Administration (USFDA) has closed the inspection with 6 observations at the Company's API site situated at Changodar, Ahmedabad.
This PAI-cum-GMP USFDA inspection was conducted from December 14 to December 22, 2023.
"There were no Data Integrity related observations. There are no repeat observations from the previous inspection. There are 4 DMFs of this site under approval with the USFDA. The Company will closely work with the USFDA to address the observations" the Company informed in a recent BSE filing.
Medical Dialogues team had earlier announced that the Company had received the Establishment Investigation Report (EIR) report from the USFDA for the injectables manufacturing facility at Zydus Biotech Park located at Changodar, Ahmedabad.
Read also: Zydus receives EIR for injectables manufacturing facility at Zydus Biotech Park, Ahmedabad
Formerly known as Cadila Healthcare Limited, Zydus Lifesciences Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad. The company is primarily engaged in the production of generic drugs. Cadila was founded in 1952 by Ramanbhai Patel.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.